← Insider buys
MRNA

Moderna, Inc. · Healthcare

Director Noubar Afeyan sold $1.4M of Moderna, Inc.

Sold$1,353,600
$135.36Price
10,000Shares

What MRNA did after the filing

Filed Oct 14Copier in Oct 17
The stock from Mon, Oct 17 open, $135.52
+27.8%
S&P 500, same days
+8.6%

Measured over 30 trading days, to the Nov 29 close.

Traded Wed, Oct 12. Filed Fri, Oct 14, 7:30 PM ET, after the close. Returns use the Oct 17 open and the Nov 29 close. Not investment advice.